![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
Background: Aeromonas species can cause various infections including bacteremia, gastroenteritis, cholangitis, and wound infections. To date, most studies on Aeromonas species have been reported from countries other than Japan. The aim of this study, therefore, was to evaluate Aeromonas bacteremia in Japan. Methods: We reviewed the medical records of patients with Aeromonas bacteremia from January 1994 to December 2010 in Toranomon Hospital, Tokyo, and Toranomon Hospital Kajigaya, Kanagawa, Japan. Results: Thirty-six cases of Aeromonas bacteremia were identified. Of these 36 strains, 18 were Aeromonas caviae, 13 were Aeromonas hydrophila, and 5 were Aeromonas veronii biovar sobria. The underlying diseases were solid tumor (21 cases), chronic hepatic disease (13 cases), diabetes mellitus (9 cases), hematological malignancies (4 cases), autosomal dominant polycystic kidney disease (2 cases), and aplastic anemia (2 cases). Patients with a solid tumor more frequently presented with A. caviae bacteremia than non-A. caviae bacteremia (14/18 vs 7/18; p = 0.041). Additionally, 16 of the 36 episodes were polymicrobial, and of these, 12 had stenosis or stasis of the bile duct or pancreatic duct (75%). The overall 30-day mortality was 19%. Conclusions: To the best of our knowledge, this is the first report to identify A. caviae as the most frequent causative pathogen of Aeromonas bacteremia in Japan. Additionally, compared with previous studies, most patients in our study had solid tumors. These findings suggest that the characteristics of Aeromonas bacteremia vary among study populations.
Acknowledgements
We thank the staff of the microbiology laboratory of Toranomon Hospital (Ms Hiroko Inagawa, Ms Chikako Okada, Ms Reiko Yabusaki, Ms Mayumi Yamanaka, Ms Hiromi Baba, Ms Noriko Watahiki, Mr Masaru Baba, Ms Emiko Miyajima, Mr Tomohiro Tsubaki, Ms Yoshiko Yamada, Ms Chiemi Takezawa, Ms Mayumi Nakajyo, Mr Takashi Kikuchi, and Ms Noriko Chida) for performing identification and drug susceptibility tests. This work was presented in part at the 49th annual meeting of the Infectious Diseases Society of America (IDSA), Boston, USA, October 20–23, 2011.
Declaration of interest: The authors have no conflicts of interest to disclose.